Cargando…

Biological markers for early detection and pharmacological treatment of Alzheimer's disease

The introduction of biological markers in the clinical management of Alzheimer's disease (AD) will not only improve diagnosis relating to early detection of neuropathology with underlying molecular mechanisms, but also provides tools for the assessment of objective treatment benefits. In this r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hampel, Harald, Broich, Karl, Hoessler, Yvonne, Pantel, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2009
Materias:	Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181918/ https://www.ncbi.nlm.nih.gov/pubmed/19585950

Ejemplares similares

Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
por: Haberstroh, Julia, et al.
Publicado: (2010)

Early detection of Alzheimer's disease: new diagnostic criteria
por: Dubois, Bruno, et al.
Publicado: (2009)

Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
por: Hadar, Adva, et al.
Publicado: (2018)

Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
por: Karakaya, Tarik, et al.
Publicado: (2013)

Biological markers of generalized anxiety disorder
por: Maron, Eduard, et al.
Publicado: (2017)

Mechanism-based treatments for Alzheimer's disease
por: Davies, Peter, et al.
Publicado: (2009)

Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 
por: Hampel, Harald, et al.
Publicado: (2019)

β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification
por: Hampel, Harald, et al.
Publicado: (2020)

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
por: Gerlach, Manfred, et al.
Publicado: (2011)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo
por: Cejka, D, et al.
Publicado: (2009)

A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
por: Moss, Donald E, et al.
Publicado: (2013)

Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
por: Chen, Lei, et al.
Publicado: (2010)

Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy
por: Jimeno, A, et al.
Publicado: (2007)

Novel strategies for the prevention of dementia from Alzheimer's disease
por: Shineman, Diana W., et al.
Publicado: (2009)

The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
por: Millan, Mark J.
Publicado: (2014)

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges
por: O'Bryant, Sid E., et al.
Publicado: (2015)

Measuring the biological effect of presurgical metformin treatment in endometrial cancer
por: Sivalingam, V N, et al.
Publicado: (2016)

Salivating for Knowledge: Potential Pharmacological Agents in Tick Saliva
por: Hovius, Joppe W. R, et al.
Publicado: (2008)

Body surface potential mapping detects early disease onset in plakophilin-2-pathogenic variant carriers
por: Kloosterman, Manon, et al.
Publicado: (2023)

The Application of Cocaine to the Eye as an Anæsthetic
por: Koller, Karl
Publicado: (1885)

Medical Electricity: The State of Our Knowledge Concerning the Application of Electricity to the Treatment of Disease
por: Becquerel,
Publicado: (1869)

Medical Electricity: The State of Our Knowledge Concerning the Application of Electricity to the Treatment of Disease
por: Becquerel,
Publicado: (1869)

The Usefulness of Biological and Neuroimaging Markers for the Diagnosis of Early-Onset Alzheimer's Disease
por: Padovani, Alessandro, et al.
Publicado: (2011)

Modeling Early Radiation DNA Damage Occurring During (177)Lu-DOTATATE Radionuclide Therapy
por: Tamborino, Giulia, et al.
Publicado: (2022)

The Treatment of Asthma
por: Rodet, Paul, et al.
Publicado: (1885)

Anticonvulsants in the treatment of aggression in the demented elderly: an update
por: Amann, Benedikt, et al.
Publicado: (2009)

Operative Treatment of Astigmatism
por: Pflüger,
Publicado: (1896)

Treatment of Fractures by Massage
por: Berne,, et al.
Publicado: (1888)

The Treatment of Psychoses by Opium
Publicado: (1889)

Treatment of Cholera with Iodine
Publicado: (1885)

The Etiology of Chorea and Its Treatment
por: Besançon,, et al.
Publicado: (1902)

The Treatment of Phthisis by Antiseptic Inhalations
por: Couetoux, Rene, et al.
Publicado: (1885)

On the Local Treatment of Pulmonary Cavities
por: Mosler, F.
Publicado: (1874)

On the Local Treatment of Pulmonary Cavities
por: Mosler, F.
Publicado: (1874)

Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
por: Ouyang, Jia-Ying, et al.
Publicado: (2023)

Operations for Empyema, Particularly Their After-Treatment
por: Holsti, Hugo, et al.
Publicado: (1889)

Prof. Lefort on the Antiseptic Treatment of Wounds
Publicado: (1879)

The Treatment of the Acute Inflammations of the Middle Ear
por: Weber-Liel,
Publicado: (1877)

The Influence on Mortality of the Antiseptic Treatment in Wounds on the Head
por: Mynter, Herman
Publicado: (1879)

Cannot write session to /tmp/vufind_sessions/sess_27tt4sd7q0al2jaf6hd1ngtneb